Thus, despite experimental data suggesting a role for CCR2 and CCL2 in PNI [30], in this cohort of locally advanced prostate cancer, we found no significant change in CCR2 or CCL2 protein expression in prostate cancer patients in relation to PNI. The gene discussed is CCL2; the disease is prostate carcinoma.